Drugs / Z-521
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01237288 | Sep 2010 → Apr 2013 | hypophosphatemic rickets | Zeria Pharmaceutical | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2012-03-29 | Zeria Pharmaceutical | Regulatory 低リン血症治療剤「Z-521」の製造販売承認申請について （PDF ファイル 0.12MB） zeria.co.jp ↗ |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2012-03-29 | Zeria Pharmaceutical | 低リン血症治療剤「Z-521」の製造販売承認申請について （PDF ファイル 0.12MB） zeria.co.jp ↗ |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Z-521 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01237288 ↗ |